asts Weekly Update MultiBriefs

Study: Age, medications play role in post-transplant cancer rate

Organ transplant recipients regularly receive immunosuppressive drugs to help minimize the risk of rejection, but those drugs come with significant risks of their own, including leaving patients open to predatory infections and even certain...

source: By Karen Zabel
Search past issues
Search products and services

Donor-transmitted disease in organ transplantation is uncommon, but possible. The LDL receptor, a key regulator of lipoprotein metabolism, is abundant in the liver. Mutations in the LDLR gene, leading to...

source: American Journal of Transplantation (login required)

The ASTS Foundation Fund the Future Campaign has a goal of raising $100,000 to fund research grants. We need your help! Please consider donating any amount.

source: ASTS

Have you gotten your copy of the ASTS 40th anniversary book yet? One free copy is available to ASTS members, and non-members can purchase a copy in the ASTS Store.

source: ASTS

ASTS, along with the American Hepato-Pancreato-Biliary Association and the Society of Surgical Oncology, will hold a consensus conference on Training in HBP Surgery Oct. 27, 2014, at the Omni San Francisco.

source: ASTS

There are complex risk-benefit tradeoffs with different transplantation strategies for end-stage liver disease patients on renal support. Using a Markov discrete-time state transition model, scientists...

source: Liver Transplantation (login required)

Uric acid is associated with increased mortality in kidney transplant recipients, but it is uncertain if this involves endothelial dysfunction. We hypothesized, first, that there was an association between uric acid and endothelial...

source: Clinical Transplantation (login required)


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to ASTS NewsBrief

*First Name:
*Last Name:
Street Address:
State / Province:
Are you a member of ASTS? Yes   No
Privacy Policy